Clinical trial
Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer
NCT00002487 · Ottawa Regional Cancer Centre, Other · Unknown status
Key facts
| NCT number | NCT00002487 |
|---|---|
| Title | Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer |
| Official title | INTRAPERITONEAL METHOTREXATE AND DIPYRIDAMOLE AS SALVAGE TREATMENT FOR ADVANCED OVARIAN CARCINOMA |
| Lead sponsor | Ottawa Regional Cancer Centre, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | dipyridamole, methotrexate |
| Start date | Jul 1, 1991 |
| First posted | Aug 30, 2004 |
| Last update posted | Sep 17, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: